The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and clinicogenomic biomarkers of response to dual versus single agent checkpoint inhibitor therapy in untreated metastatic non-small cell lung cancer.
 
Daniel Boiarsky
Employment - Tectonic Therapeutic (I)
Stock and Other Ownership Interests - Tectonic Therapeutic
 
Lingzhi Hong
No Relationships to Disclose
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Guidepoint Inc; Regeneron
 
Alissa Jamie Cooper
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Maliazurina B Saad
No Relationships to Disclose
 
Arielle Elkrief
No Relationships to Disclose
 
Alessandro Di Federico
No Relationships to Disclose
 
Muhammad Aminu
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Jeff Lewis
No Relationships to Disclose
 
Don Lynn Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar; Revolution Medicines
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Lilly; Menarini; Onconova Therapeutics; Sanofi
Research Funding - Astellas Pharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen; Mirati Therapeutics (Inst); NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
Ara A. Vaporciyan
Travel, Accommodations, Expenses - AstraZeneca/Greece
 
Xiuning Le
Stock and Other Ownership Interests - BlossomHill Therapeutics
Consulting or Advisory Role - Abbvie; ABION; ArriVent Biopharma; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Novartis; Regeneron; Sensei Biotherapeutics; Spectrum Pharmaceuticals; Systimmune; Taiho Pharmaceutical
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); EMD Serono (Inst); Janssen (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Spectrum Pharmaceuticals
 
J. Jack Lee
Honoraria - AstraZeneca; AstraZeneca
 
John Heymach
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; DAVA Pharmaceuticals; EMD Serono; Genentech/Roche; GlaxoSmithKline; Hengrui Pharmaceutical; Janssen; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; Nexus Health Systems; Pneuma Respiratory; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - DAVA Pharmaceuticals; IDEOlogy Health; MJH Life Sciences
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Mirati Therapeutics; Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
Jia Wu
No Relationships to Disclose
 
Adam Jacob Schoenfeld
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Enara Bio; Heat Biologics; Immunocore; Iovance Biotherapeutics; Johnson & Johnson/Janssen; KSQ Therapeutics; Legend Biotech; Lyell Immunopharma; Merck; Oppenheimer; Perceptive Advisors; Prelude Therapeutics; Umoja Biopharma
Research Funding - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Mark M. Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Jianjun Zhang
Honoraria - CancerNet; Geneplus; Geneplus; Hengrui Medicine; innovent biologics; Innovent Biologics; Innovent Biologics; Origimed; Roche; Sino-USA Biomedical Platform; Suzhou Medical Association; Varian Medical Systems; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Hunan Cancer Hospital; Johnson & Johnson/Janssen; Novartis
Research Funding - Merck; Novartis
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
Natalie I Vokes
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; EMD Serono; Lilly; OncoCyte; Pfizer; Regeneron; Remedy Health; Sanofi; Sanofi/Regeneron; Summit pharmaceuticals; Tempus; Xencor
Research Funding - Circulo; Mirati Therapeutics; OncoCyte
Travel, Accommodations, Expenses - Regeneron